Optimizing Smoking Cessation for People With HIV/AIDS Who Smoke
Smoking, HIV
About this trial
This is an interventional treatment trial for Smoking
Eligibility Criteria
Study Inclusion Criteria:
- Confirmed chart diagnosis of a HIV and receiving HIV treatment at the participating HIV clinic.
- Age 18 years or older.
- Currently self-report smoking 10 cigarettes per day
- Motivation to quit within the next 6 months (score 5-8 on the Abrams and Briener Readiness to Quit Ladder);
- Does not meet criteria for current DSM 5 moderate or severe alcohol use disorder or moderate or severe substance use disorder as established by the MINI drug and alcohol sections (in the last 3 months)
- Able to read and speak English
- Willingness and ability to provide informed consent to participate.
Study Exclusion Criteria:
The exclusion criteria are designed to maximize safety by minimizing drug interactions or worsening pre-existing comorbid psychiatric or medical conditions:
- Current suicidal thoughts or ideation (past week); recent suicidal thoughts or ideation (past 6 months) or recent suicide attempt (past 6 months) as assessed by the Columbia-Suicide Severity Rating Scale (C-SSRS).
- Previous allergic reaction or hypersensitivity to Varenicline (by participant report ever in lifetime)
- Pregnant, nursing, or becoming pregnant during the study (pregnancy test).
- Current use of any medication that would interfere with the protocol in the opinion of Medically Accountable Physician including use of bupropion targeting nicotine dependence
- Moderate to severe renal impairment (< 30 mL/min)--As determined by a physician assessment, chart review or thru blood work
- Unstable cardiovascular disease (myocardial infarction within past year, uncontrolled arrhythmia, uncontrolled angina, uncontrolled congestive heart failure, electrocardiogram abnormality with QTC > 500 msec, cerebrovascular event within past year). (As determined by a physician assessment, chart review and/or EKG)
- Meets criteria for dementia by scoring below 10 on the Hopkins HIV Dementia Scale. This criterion is included to ensure the sample consists of participants who are cognitively able to engage in the study procedures
- Scores <5 ppm of expired carbon monoxide (CO) on the Smokelyzer
- The study physician believes that the individual is not medially stable enough to participate in the study. This exclusion will be based on a review of the individual's past medical history and current medical status.
- Recent use of Varenicline (by participant report in the past 3 months)
Sites / Locations
- University of Maryland Medical Center, Midtown Campus
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Placebo Comparator
Active Comparator
Active Comparator
Varenicline and Standard of Care
Placebo and Standard of Care
Positively Smoke Free and Placebo
Positively Smoke Free and Varenicline
Participants will receive varenicline and standard of care
Participants will receive placebo and standard of care
Participant will receive Positively Smoke Free (a tailored behavioral intervention) and Placebo
Participant will receive Positively Smoke Free (a tailored behavioral intervention) and Varenicline